Epsilon M&A Deal Report - HAC Pharma
Transaction Multiples for the Valuation of Private Companies
Private group led by Turenne Santé and BNP Paribas Développement / HAC Pharma
No EMAT :
109042
Announced Date :
31/01/2022
Type :
MBO (Management Buy Out)
Deal Value :
Yes
Acquirer :
Private group led by Turenne Santé and BNP Paribas Développement
Target :
HAC Pharma
Country :
France
Sector of activity :
- Laboratories > Pharmaceuticals & Cosmetics > Health, Pharmaceuticals & Biotechnology > Biomedical Research Laboratory
Business Description :
Founded in 2007, H.A.C. Pharma is a provider of therapeutic and pharmaceutical laboratory services. > Distributes fifteen specialty drugs in eight different therapeutic areas covering in particular...
Transaction multiples available
| EV/ Sales |
EV/ Gross Profit |
EV/ EBITDA |
EV/ EBIT |
Eq/ PBT |
P/E | Price to Book |
Specific multiple(s) |
|
|---|---|---|---|---|---|---|---|---|
| Historic | 
|
|
|
|||||
| Current |
Rating :
***
|
|
Multiple available |
| n.s. | Multiple calculated, but not significant |
Source: Epsilon Research / EMAT
Comparable Transactions
- Number of EMAT Reports / sub-sector « Biomedical Research Laboratory » = 34
| Date | Acquirer | Target | Country | Multiples | See details |
| 27/04/2022 | Getinge | Fluoptics | Isère | ** | 108896 |
| 19/08/2021 | Vitruvian Partners | Fotona | Slovenia | * | 108842 |
Source: Epsilon Research / EMAT
